SaraIsabelPaiMDPhD

Head & Neck Oncologic Surgery

Massachusetts General Hospital, Harvard Medical School/ Director, Translational Head and Neck Cancer Research

Telehealth Available

Overview of Dr. Pai

Dr. Sara Pai is an otolaryngologist in New Haven, CT and is affiliated with multiple hospitals in the area, including Yale-New Haven Hospital and Massachusetts General Hospital. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice 15 years. She is one of 150 doctors at Massachusetts General Hospital and one of 76 doctors at Yale-New Haven Hospital who specialize in Otolaryngology (ENT). She also speaks multiple languages, including Spanish and Korean. She has more than 100 publications and over 500 citings.

Office
35 Park St
Smilow Cancer Hospital at Yale New Haven
New Haven, CT 06510
Book by Phone+1(763) 710-3027

Education & Training

Johns Hopkins UniversityResidency, Otolaryngology - Head and Neck Surgery, 2003 - 2007
Johns Hopkins UniversityInternship, Surgery, 2002 - 2003
Johns Hopkins UniversityInternship, Otolaryngology - Head and Neck Surgery, 2002 - 2003
Johns Hopkins University School of MedicineClass of 2002

Certifications & Licensure

MA State Medical License 2014 - 2026
CT State Medical License 2023 - 2025
MD State Medical License 2007 - 2025
ME State Medical License 2020 - 2021
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FACS) American College of Surgeons
Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Clinical Trials

Lenvatinib and Pembrolizumab Combination Therapy In HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal, and/or Pulmonary Involvement Start of enrollment: 2024 Jul 01
Not yet recruiting
Phase 2

Publications & Presentations

PubMed

669 citations
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer
Michael Mingzhao Xing, Ali S. Alzahrani, Kathryn A. Carson, David Viola, Rossella Elisei
JAMA. 2013-04-10
576 citations
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
Christopher Garris, Sean P. Arlauckas, Rainer H. Kohler, Marcel P. Trefny, Seth B. Garren
Immunity. 2018-12-18
29 citations
Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study
Karen S. Anderson, Jennifer E. Gerber, Gypsyamber D'Souza, Sara I. Pai, Julia N. Cheng
Oral Oncology. 2015-08-01

Lectures

A phase II study of pembrolizumab for HPV-associated papilloma patients with laryngeal, tracheal, and/or pulmonary involvement.
2019 ASCO Annual Meeting - 6/1/2019
ICR gene signature to identify differential immune landscapes in anatomic subsites of head and neck squamous cell carcinomas and implications in personalized medicine.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018